Skip to content

Opening book details…

About this Medicine article

Multicenter observational study of the efficacy and safety of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim analysis by Laktionov, K.; Arzumanyan, A.; Bolotina, L.; Breder, V.; Buevich, N.; Danilova, A.; Filippova, E.; Kornietskaya, A.; Kramchaninov, M.; Kushniruk, E.; Latipova, D.; Moiseenko, F.; Nikitina, T.; Orlov, S.; Orlova, R.; Protsenko, S.; Sarantseva, K.; Stroyakovskiy, D.; Ionova, T. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Laktionov, K.; Arzumanyan, A.; Bolotina, L.; Breder, V.; Buevich, N.; Danilova, A.; Filippova, E.; Kornietskaya, A.; Kramchaninov, M.; Kushniruk, E.; Latipova, D.; Moiseenko, F.; Nikitina, T.; Orlov, S.; Orlova, R.; Protsenko, S.; Sarantseva, K.; Stroyakovskiy, D.; Ionova, T.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2017
Field
Medicine (Health Sciences)

More by Laktionov, K.; Arzumanyan, A.; Bolotina, L.; Breder, V.; Buevich, N.; Danilova, A.; Filippova, E.; Kornietskaya, A.; Kramchaninov, M.; Kushniruk, E.; Latipova, D.; Moiseenko, F.; Nikitina, T.; Orlov, S.; Orlova, R.; Protsenko, S.; Sarantseva, K.; Stroyakovskiy, D.; Ionova, T.

Browse all works by Laktionov, K.; Arzumanyan, A.; Bolotina, L.; Breder, V.; Buevich, N.; Danilova, A.; Filippova, E.; Kornietskaya, A.; Kramchaninov, M.; Kushniruk, E.; Latipova, D.; Moiseenko, F.; Nikitina, T.; Orlov, S.; Orlova, R.; Protsenko, S.; Sarantseva, K.; Stroyakovskiy, D.; Ionova, T.